vs
Cooper Companies (The)（COO）与思佳讯（SWKS）财务数据对比。点击上方公司名可切换其他公司
Cooper Companies (The)的季度营收约是思佳讯的1.1倍（$1.1B vs $943.7M），Cooper Companies (The)净利率更高（7.9% vs 3.8%，领先4.2%），Cooper Companies (The)同比增速更快（4.6% vs -1.0%），过去两年Cooper Companies (The)的营收复合增速更高（6.9% vs 2.1%）
CooperCompanies是总部位于美国加利福尼亚州圣拉蒙的全球医疗设备企业，旗下设有两大业务单元：主营隐形眼镜生产的库博光学，以及面向女性健康市场提供医疗设备、生育及基因组相关产品的库博外科。
思佳讯是总部位于美国加利福尼亚州尔湾的半导体企业，公司股票在纳斯达克全球精选市场挂牌交易，股票代码为SWKS，同时也是标普500指数的成分股之一，在全球射频半导体领域拥有较高市场地位。
COO vs SWKS — 直观对比
营收规模更大
COO
是对方的1.1倍
$943.7M
营收增速更快
COO
高出5.6%
-1.0%
净利率更高
COO
高出4.2%
3.8%
两年增速更快
COO
近两年复合增速
2.1%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.1B | $943.7M |
| 净利润 | $84.6M | $35.6M |
| 毛利率 | 61.1% | 40.8% |
| 营业利润率 | 13.2% | 4.5% |
| 净利率 | 7.9% | 3.8% |
| 营收同比 | 4.6% | -1.0% |
| 净利润同比 | -28.0% | -48.2% |
| 每股收益（稀释后） | $0.42 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收COOSWKS
| Q2 26 | — | $943.7M | ||
| Q1 26 | — | $1.0B | ||
| Q4 25 | $1.1B | $1.1B | ||
| Q3 25 | $1.1B | — | ||
| Q2 25 | $1.0B | $965.0M | ||
| Q1 25 | $964.7M | $953.2M | ||
| Q4 24 | $1.0B | $1.1B | ||
| Q3 24 | $1.0B | $1.0B |
净利润COOSWKS
| Q2 26 | — | $35.6M | ||
| Q1 26 | — | $79.2M | ||
| Q4 25 | $84.6M | $141.4M | ||
| Q3 25 | $98.3M | — | ||
| Q2 25 | $87.7M | $105.0M | ||
| Q1 25 | $104.3M | $68.7M | ||
| Q4 24 | $117.5M | $162.0M | ||
| Q3 24 | $104.7M | $60.5M |
毛利率COOSWKS
| Q2 26 | — | 40.8% | ||
| Q1 26 | — | 41.3% | ||
| Q4 25 | 61.1% | 40.7% | ||
| Q3 25 | 65.3% | — | ||
| Q2 25 | 67.8% | 41.6% | ||
| Q1 25 | 68.4% | 41.1% | ||
| Q4 24 | 66.5% | 41.4% | ||
| Q3 24 | 66.1% | 41.9% |
营业利润率COOSWKS
| Q2 26 | — | 4.5% | ||
| Q1 26 | — | 10.0% | ||
| Q4 25 | 13.2% | 10.1% | ||
| Q3 25 | 16.6% | — | ||
| Q2 25 | 18.4% | 11.5% | ||
| Q1 25 | 18.9% | 10.2% | ||
| Q4 24 | 19.5% | 16.9% | ||
| Q3 24 | 19.2% | 5.8% |
净利率COOSWKS
| Q2 26 | — | 3.8% | ||
| Q1 26 | — | 7.6% | ||
| Q4 25 | 7.9% | 12.9% | ||
| Q3 25 | 9.3% | — | ||
| Q2 25 | 8.7% | 10.9% | ||
| Q1 25 | 10.8% | 7.2% | ||
| Q4 24 | 11.5% | 15.2% | ||
| Q3 24 | 10.4% | 5.9% |
每股收益（稀释后）COOSWKS
| Q2 26 | — | $0.24 | ||
| Q1 26 | — | $0.53 | ||
| Q4 25 | $0.42 | $0.95 | ||
| Q3 25 | $0.49 | — | ||
| Q2 25 | $0.44 | $0.70 | ||
| Q1 25 | $0.52 | $0.43 | ||
| Q4 24 | $0.59 | $1.00 | ||
| Q3 24 | $0.52 | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $110.6M | — |
| 总债务越低越好 | $2.5B | — |
| 股东权益账面价值 | $8.2B | $5.8B |
| 总资产 | $12.4B | $7.9B |
| 负债/权益比越低杠杆越低 | 0.30× | — |
8季度趋势，按日历期对齐
现金及短期投资COOSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | $1.6B | ||
| Q4 25 | $110.6M | $1.4B | ||
| Q3 25 | $124.9M | — | ||
| Q2 25 | $116.2M | $1.3B | ||
| Q1 25 | $100.9M | $1.5B | ||
| Q4 24 | $107.6M | $1.7B | ||
| Q3 24 | $109.7M | $1.6B |
总债务COOSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | $496.6M | ||
| Q4 25 | $2.5B | $496.4M | ||
| Q3 25 | $2.4B | — | ||
| Q2 25 | $2.5B | $496.2M | ||
| Q1 25 | $2.5B | $995.1M | ||
| Q4 24 | $2.6B | $994.7M | ||
| Q3 24 | $2.6B | $994.3M |
股东权益COOSWKS
| Q2 26 | — | $5.8B | ||
| Q1 26 | — | $5.8B | ||
| Q4 25 | $8.2B | $5.8B | ||
| Q3 25 | $8.4B | — | ||
| Q2 25 | $8.3B | $5.7B | ||
| Q1 25 | $8.1B | $5.9B | ||
| Q4 24 | $8.1B | $6.4B | ||
| Q3 24 | $7.9B | $6.3B |
总资产COOSWKS
| Q2 26 | — | $7.9B | ||
| Q1 26 | — | $7.9B | ||
| Q4 25 | $12.4B | $7.9B | ||
| Q3 25 | $12.4B | — | ||
| Q2 25 | $12.4B | $7.7B | ||
| Q1 25 | $12.2B | $7.9B | ||
| Q4 24 | $12.3B | $8.3B | ||
| Q3 24 | $12.1B | $8.3B |
负债/权益比COOSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | 0.09× | ||
| Q4 25 | 0.30× | 0.09× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.30× | 0.09× | ||
| Q1 25 | 0.31× | 0.17× | ||
| Q4 24 | 0.32× | 0.16× | ||
| Q3 24 | 0.33× | 0.16× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $247.9M | $50.3M |
| 自由现金流经营现金流 - 资本支出 | $149.9M | — |
| 自由现金流率自由现金流/营收 | 14.1% | — |
| 资本支出强度资本支出/营收 | 9.2% | 8.7% |
| 现金转化率经营现金流/净利润 | 2.93× | 1.41× |
| 过去12个月自由现金流最近4个季度 | $433.7M | — |
8季度趋势，按日历期对齐
经营现金流COOSWKS
| Q2 26 | — | $50.3M | ||
| Q1 26 | — | $395.5M | ||
| Q4 25 | $247.9M | $200.0M | ||
| Q3 25 | $261.4M | — | ||
| Q2 25 | $96.2M | $314.2M | ||
| Q1 25 | $190.6M | $409.4M | ||
| Q4 24 | $268.1M | $377.2M | ||
| Q3 24 | $207.5M | $476.1M |
自由现金流COOSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | $339.0M | ||
| Q4 25 | $149.9M | $144.0M | ||
| Q3 25 | $164.5M | — | ||
| Q2 25 | $18.1M | $252.7M | ||
| Q1 25 | $101.2M | $370.9M | ||
| Q4 24 | $128.1M | $338.2M | ||
| Q3 24 | $118.5M | $393.3M |
自由现金流率COOSWKS
| Q2 26 | — | — | ||
| Q1 26 | — | 32.7% | ||
| Q4 25 | 14.1% | 13.1% | ||
| Q3 25 | 15.5% | — | ||
| Q2 25 | 1.8% | 26.2% | ||
| Q1 25 | 10.5% | 38.9% | ||
| Q4 24 | 12.6% | 31.7% | ||
| Q3 24 | 11.8% | 38.4% |
资本支出强度COOSWKS
| Q2 26 | — | 8.7% | ||
| Q1 26 | — | 5.5% | ||
| Q4 25 | 9.2% | 5.1% | ||
| Q3 25 | 9.1% | — | ||
| Q2 25 | 7.8% | 6.4% | ||
| Q1 25 | 9.3% | 4.0% | ||
| Q4 24 | 13.7% | 3.6% | ||
| Q3 24 | 8.9% | 8.1% |
现金转化率COOSWKS
| Q2 26 | — | 1.41× | ||
| Q1 26 | — | 4.99× | ||
| Q4 25 | 2.93× | 1.41× | ||
| Q3 25 | 2.66× | — | ||
| Q2 25 | 1.10× | 2.99× | ||
| Q1 25 | 1.83× | 5.96× | ||
| Q4 24 | 2.28× | 2.33× | ||
| Q3 24 | 1.98× | 7.87× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
COO
| Sphere Other | $365.0M | 34% |
| Toric And Multifocal | $344.7M | 32% |
| Office And Surgical | $214.5M | 20% |
| Fertility | $140.9M | 13% |
SWKS
暂无分部数据
